Hepatopulmonary syndrome: More than just a matter of tone?

Hepatology

Volumn 43, Issue 5, 2006, Pages 912-914

  Fallon, Michael B ^a,b  

^a 290MCLM ^*  (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTERIAL OXYGEN TENSION; BLOOD VESSEL TONE; EDITORIAL; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; LIVER TRANSPLANTATION; LUNG ALVEOLUS OXYGEN TENSION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

ENDOTHELIUM, VASCULAR; HEPATOPULMONARY SYNDROME; HUMANS;

EID: 33646576239     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22198     Document Type: Editorial

References (21)

1. Rodriguez-Roisin R, Agusti AG, Roca J. The hepatopulmonary syndrome: new name, old complexities. Thorax 1992;47:897-902.
2. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995;109:1283-1288.
3. Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O, Muller C. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002;51:853-859.
4. Schenk P, Schoniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003;125:1042-1052.
5. Swanson K, Wiesner R, Krowka M. Natural history of hepatopulmonary syndrome: Impact of liver transplantation. HEPATOLOGY 2005;41:1122-1129.
6. Arguedas M, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. HEPATOLOGY 2003;37:192-197.
7. Fallon MB, Abrams GA, Luo B, Hou Z, Dai J, Ku DD. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997;113:606-614.
8. Nunes H, Lebrec D, Mazmanian M, Capron F, Heller J, Tazi KA, et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 2001;164:879-885.
9. Ling Y, Zhang J, Luo B, Song D, Liu L, Tang L, et al. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of experimental hepatopulmonary syndrome. HEPATOLOGY 2004;39:1593-1602.
10. Rabiller A, Nunes H, Lebrec D, Tazi KA, Wartski M, Dulmet E, et al. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 2002;166:514-517.
11. Zhang J, Ling Y, Luo B, Tang L, Stockard C, Grizzle WE, Fallon MB. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology 2003;125:1441-1451.
12. Rolla G, Brussino L, Colagrande P. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med 1998;129:375-378.
13. Arguedas MR, Drake BB, Kapoor A, Fallon MB. Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome. Gastroenterology 2005;128:328-333.
14. Brussino L, Bucca C, Morello M, Scappaticci E, Mauro M, Rolla G. Effect on dyspnoea and hypoxaemia of inhaled NG-nitro-L-arginine methyl ester in hepatopulmonary syndrome. Lancet 2003;362:43-44.
15. Schenk P, Madl C, Rezale-Majd S, Lehr S, Muller C. Methylene blue improves the hepatopulmonaiy syndrome. Ann Int Med 2000;133:701-706.
16. Schraufnagel D, Malik R, Goel V, Ohara N, Chang S. Lung capillary changes in hepatic cirrhosis in rats. Am J Physiol 1997;272:L139-L147.
17. Berthelot P, Walter JG, Sherlock S, Reid L. Arterial changes in the lungs in cirrhosis of the liver-lung spider nevi. N Engl J Med 1966;274:291-298.
18. Philit F, Wiesendanger T, Gille D, Boillot O, Cordier J. Late resolution of hepatopulmonary syndrome after liver transplantation. Respiration 1997;64:173-175.
19. Gómez F, Barbera JA, Roca J, Burgos F, Gistau C, Rodriguez-Roisin R. Effects of Nebulized NG-nitro-L-arginine methyl ester in patients with hepatopulmonaiy syndrome. HEPATOLOGY 2006;43:1084-1091.
20. Rolla G, Brussino L, Dutto L, Ottobrelli A, Bucca C. Smoking and hypoxemia caused by hepatopulmonary syndrome before and after liver transplantation. HEPATOLOGY 2001;34:430-431.
21. Langer D, Shah V. Nitric oxide and portal hypertension: Interface of vasoreactivity and angiogenesis. J Hepatol 2006;44:209-216.